Simeng Suy

2.1k total citations
85 papers, 1.1k citations indexed

About

Simeng Suy is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Simeng Suy has authored 85 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 36 papers in Radiation and 23 papers in Surgery. Recurrent topics in Simeng Suy's work include Prostate Cancer Diagnosis and Treatment (60 papers), Prostate Cancer Treatment and Research (45 papers) and Advanced Radiotherapy Techniques (36 papers). Simeng Suy is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (60 papers), Prostate Cancer Treatment and Research (45 papers) and Advanced Radiotherapy Techniques (36 papers). Simeng Suy collaborates with scholars based in United States, Canada and United Kingdom. Simeng Suy's co-authors include Sean P. Collins, Brian T. Collins, Siyuan Lei, Anatoly Dritschilo, Leonard N. Chen, John H. Lynch, Thomas Yung, Joy S. Kim, Eric Anderson and Eric K. Oermann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Simeng Suy

78 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Simeng Suy 889 574 213 138 124 85 1.1k
Ronald Shapiro 328 0.4× 233 0.4× 163 0.8× 69 0.5× 52 0.4× 17 455
Pedro Bilbao 237 0.3× 147 0.3× 137 0.6× 70 0.5× 111 0.9× 32 449
John J. Haluschak 661 0.7× 77 0.1× 71 0.3× 284 2.1× 119 1.0× 8 763
Adrian Wong 258 0.3× 194 0.3× 153 0.7× 294 2.1× 325 2.6× 15 642
Michelle H. Braccioforte 662 0.7× 132 0.2× 59 0.3× 121 0.9× 107 0.9× 52 786
C.A. Lawton 294 0.3× 81 0.1× 67 0.3× 93 0.7× 128 1.0× 53 482
David Wetherell 770 0.9× 48 0.1× 432 2.0× 100 0.7× 60 0.5× 18 883
L Buffoni 498 0.6× 117 0.2× 110 0.5× 321 2.3× 87 0.7× 49 812
H. Kucera 146 0.2× 71 0.1× 65 0.3× 86 0.6× 310 2.5× 83 1.0k
Jerald Katcher 511 0.6× 129 0.2× 23 0.1× 70 0.5× 109 0.9× 10 589

Countries citing papers authored by Simeng Suy

Since Specialization
Citations

This map shows the geographic impact of Simeng Suy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simeng Suy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simeng Suy more than expected).

Fields of papers citing papers by Simeng Suy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simeng Suy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simeng Suy. The network helps show where Simeng Suy may publish in the future.

Co-authorship network of co-authors of Simeng Suy

This figure shows the co-authorship network connecting the top 25 collaborators of Simeng Suy. A scholar is included among the top collaborators of Simeng Suy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simeng Suy. Simeng Suy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zwart, Alan, Deepak Kumar, Paul Leger, et al.. (2024). The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigue. Frontiers in Oncology. 14. 1412786–1412786.
3.
Zwart, Alan, Dinesh Kumar, Paul Leger, et al.. (2024). Impact of neoadjuvant relugolix on patient-reported sexual function and bother. Frontiers in Oncology. 14. 1377103–1377103. 1 indexed citations
4.
Repka, Michael, Tamir Sholklapper, Alan Zwart, et al.. (2024). Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer. Frontiers in Oncology. 14. 1381134–1381134. 2 indexed citations
5.
6.
Xiao, Jerry, Alan Zwart, Thomas Yung, et al.. (2023). Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer. Frontiers in Oncology. 13. 1289249–1289249. 1 indexed citations
7.
8.
Sholklapper, Tamir, Siyuan Lei, Abdul Rashid, et al.. (2023). Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes. Frontiers in Oncology. 13. 1240939–1240939. 1 indexed citations
9.
Sholklapper, Tamir, Michael Creswell, Alan Zwart, et al.. (2022). Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer. Frontiers in Oncology. 12. 852844–852844. 6 indexed citations
10.
Jiang, Naomi, Donald B. Fuller, Andrew Loblaw, et al.. (2021). Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients. International Journal of Radiation Oncology*Biology*Physics. 110(3). 731–737. 40 indexed citations
11.
Aghdam, Nima, Colin Johnson, Thomas Yung, et al.. (2020). Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT). Frontiers in Oncology. 9. 1528–1528. 4 indexed citations
12.
Aghdam, Nima, Michael Repka, Ima Paydar, et al.. (2020). Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer. Frontiers in Oncology. 10. 572564–572564. 6 indexed citations
13.
Aghdam, Nima, Michael Creswell, Clayton Smith, et al.. (2020). Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate Cancer. Frontiers in Oncology. 10. 551491–551491. 2 indexed citations
14.
Johnson, Skyler B., Pamela R. Soulos, Timothy D. Shafman, et al.. (2016). Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E242–E242. 1 indexed citations
15.
Kole, Thomas P., Leonard N. Chen, Joy S. Kim, et al.. (2014). Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer. Acta Oncologica. 54(6). 832–838. 22 indexed citations
16.
Chen, Leonard N., H Wright, Sunghae Uhm, et al.. (2013). Potency preservation following stereotactic body radiation therapy for prostate cancer. Radiation Oncology. 8(1). 256–256. 22 indexed citations
17.
Ju, Andrew, Hongkun Wang, Eric K. Oermann, et al.. (2013). Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer. Radiation Oncology. 8(1). 30–30. 27 indexed citations
18.
Chen, Leonard N., Michael C. F. Tong, Siyuan Lei, et al.. (2013). Rationale for Stereotactic Body Radiation Therapy in Treating Patients with Oligometastatic Hormone-Naïve Prostate Cancer. Frontiers in Oncology. 3. 293–293. 13 indexed citations
19.
Snider, J.W., Eric K. Oermann, Viola Chen, et al.. (2012). CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Single Peripheral Lung Metastases. SHILAP Revista de lepidopterología. 2. 63–63. 14 indexed citations
20.
Vahdat, Saloomeh, Eric K. Oermann, Sean P. Collins, et al.. (2010). CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment. Journal of Hematology & Oncology. 3(1). 6–6. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald Shapiro Breakdown of academic impact, for papers by Pedro Bilbao Breakdown of academic impact, for papers by John J. Haluschak Breakdown of academic impact, for papers by Adrian Wong Breakdown of academic impact, for papers by Michelle H. Braccioforte Breakdown of academic impact, for papers by C.A. Lawton Breakdown of academic impact, for papers by David Wetherell Breakdown of academic impact, for papers by L Buffoni Breakdown of academic impact, for papers by H. Kucera Breakdown of academic impact, for papers by Jerald Katcher
Rankless by CCL
2026